SQZ Biotechnologies Company

OTCPK:SQZB 주식 보고서

시가총액: US$678.3k

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

SQZ Biotechnologies 관리

관리 기준 확인 2/4

SQZ Biotechnologies' CEO는 Howard Bernstein, Nov2022 에 임명되었습니다 의 임기는 1.75 년입니다. 는 $ 5.95K 가치에 해당하는 회사 주식의 0.2% 직접 소유합니다. 5.95K. 경영진과 이사회의 평균 재임 기간은 각각 2.7 년과 3.8 년입니다.

주요 정보

Howard Bernstein

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기1.8yrs
CEO 소유권0.2%
경영진 평균 재임 기간2.8yrs
이사회 평균 재임 기간3.9yrs

최근 관리 업데이트

Recent updates

SQZ Biotechnologies Company (NYSE:SQZ) Might Not Be As Mispriced As It Looks After Plunging 30%

Jun 26
SQZ Biotechnologies Company (NYSE:SQZ) Might Not Be As Mispriced As It Looks After Plunging 30%

We Think SQZ Biotechnologies (NYSE:SQZ) Needs To Drive Business Growth Carefully

Jan 05
We Think SQZ Biotechnologies (NYSE:SQZ) Needs To Drive Business Growth Carefully

SQZ Biotechnologies GAAP EPS of -$0.77 beats by $0.06, revenue of $3.5M misses by $0.76M

Nov 09

SQZ Biotech spikes as H.C. Wainwright initiates with Buy citing platform technology

Oct 20

Is SQZ Biotechnologies (NYSE:SQZ) In A Good Position To Deliver On Growth Plans?

Aug 20
Is SQZ Biotechnologies (NYSE:SQZ) In A Good Position To Deliver On Growth Plans?

SQZ Biotechnologies GAAP EPS of -$0.78 misses by $0.01, revenue of $3.22M misses by $0.97M

Aug 04

SQZ Biotechnologies names business chief as CFO

Jul 11

Time To Worry? Analysts Just Downgraded Their SQZ Biotechnologies Company (NYSE:SQZ) Outlook

May 17
Time To Worry? Analysts Just Downgraded Their SQZ Biotechnologies Company (NYSE:SQZ) Outlook

Here's Why We're Watching SQZ Biotechnologies' (NYSE:SQZ) Cash Burn Situation

May 02
Here's Why We're Watching SQZ Biotechnologies' (NYSE:SQZ) Cash Burn Situation

Here's Why We're Watching SQZ Biotechnologies' (NYSE:SQZ) Cash Burn Situation

Jan 11
Here's Why We're Watching SQZ Biotechnologies' (NYSE:SQZ) Cash Burn Situation

Will SQZ Biotechnologies (NYSE:SQZ) Spend Its Cash Wisely?

Jul 30
Will SQZ Biotechnologies (NYSE:SQZ) Spend Its Cash Wisely?

Need To Know: Analysts Are Much More Bullish On SQZ Biotechnologies Company (NYSE:SQZ)

May 16
Need To Know: Analysts Are Much More Bullish On SQZ Biotechnologies Company (NYSE:SQZ)

Newsflash: SQZ Biotechnologies Company (NYSE:SQZ) Analysts Have Been Trimming Their Revenue Forecasts

Mar 25
Newsflash: SQZ Biotechnologies Company (NYSE:SQZ) Analysts Have Been Trimming Their Revenue Forecasts

SQZ Biotechnologies Company (NYSE:SQZ) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Mar 20
SQZ Biotechnologies Company (NYSE:SQZ) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

We Think SQZ Biotechnologies (NYSE:SQZ) Can Afford To Drive Business Growth

Feb 01
We Think SQZ Biotechnologies (NYSE:SQZ) Can Afford To Drive Business Growth

CEO 보상 분석

Howard Bernstein 의 보수는 SQZ Biotechnologies 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2023n/an/a

-US$72m

Jun 30 2023n/an/a

-US$71m

Mar 31 2023n/an/a

-US$76m

Dec 31 2022US$2mUS$400k

-US$79m

Sep 30 2022n/an/a

-US$78m

Jun 30 2022n/an/a

-US$78m

Mar 31 2022n/an/a

-US$74m

Dec 31 2021US$1mUS$391k

-US$69m

Sep 30 2021n/an/a

-US$75m

Jun 30 2021n/an/a

-US$64m

Mar 31 2021n/an/a

-US$55m

Dec 31 2020US$750kUS$357k

-US$51m

보상 대 시장: US 시장에서 비슷한 규모의 회사에 비해 Howard 의 총 보상이 합리적인지 여부를 입증하기에는 데이터가 부족합니다.

보상과 수익: 회사가 수익성이 없는 동안 Howard 의 보상이 증가했습니다.


CEO

Howard Bernstein (67 yo)

1.8yrs

테뉴어

US$1,624,513

보상

Dr. Howard Bernstein, M.D., Ph D., had been Chief Scientific Officer of SQZ Biotechnologies Company since June 2015 until October 31, 2022. Dr. Bernstein is Director of SQZ Biotechnologies Company since Oc...


리더십 팀

이름위치테뉴어보상소유권
Howard Bernstein
Interim CEO & Director1.8yrsUS$1.62m0.20%
$ 1.4k
Lawrence Knopf
General Counsel & Secretary5yrsUS$944.03k0.0066%
$ 44.6
Marshelle Warren
Chief Medical Officer2.3yrsUS$944.27k0%
$ 0
Robert Langer
Co-Founder & Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Richard Capasso
Chief Accounting Officer2.8yrs데이터 없음데이터 없음
David First
Chief People Officer4.3yrs데이터 없음데이터 없음
Ipsita Roymoulik
Senior Vice President of CMC & QUALITY2.7yrs데이터 없음데이터 없음

2.8yrs

평균 재임 기간

62yo

평균 연령

경험이 풍부한 관리: SQZB 의 관리팀은 경험 ( 2.7 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Howard Bernstein
Interim CEO & Director1.9yrsUS$1.62m0.20%
$ 1.4k
Robert Langer
Co-Founder & Member of Scientific Advisory Boardno data데이터 없음데이터 없음
David Sachs
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Amy W. Schulman
Directorno dataUS$104.40k0.74%
$ 5.0k
Patrick V. J. Vink
Independent Director3.2yrsUS$96.62k0%
$ 0
Klavs Jensen
Independent Director11.5yrsUS$89.40k1.15%
$ 7.8k
Bernard Coulie
Independent Chairman3.2yrsUS$94.40k0%
$ 0
Marc Elia
Independent Director6.3yrsUS$86.90k0%
$ 0
Darrell Irvine
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Pushkal Garg
Independent Director6.1yrsUS$94.40k0%
$ 0
Marc Schegerin
Independent Director3.9yrsUS$94.40k0%
$ 0
Arlene Sharpe
Member of Scientific Advisory Boardno data데이터 없음데이터 없음

3.9yrs

평균 재임 기간

62yo

평균 연령

경험이 풍부한 이사회: SQZB 의 이사회경험(평균 재직 기간 3.8 년)으로 간주됩니다.